Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO

P Harter, J Sehouli, A Reuss, A Hasenburg, Giovanni Scambia, D Cibula, S Mahner, I Vergote, A Reinthaller, A Burges, L Hanker, M Pölcher, C Kurzeder, U Canzler, Ku Petry, A Obermair, E Petru, B Schmalfeldt, Domenica Lorusso, A. Du Bois

Research output: Contribution to journalArticle

172 Citations (Scopus)

Abstract

The DESKTOP I trial proposed a score for the prediction of complete cytoreduction in recurrent ovarian cancer. Resectability was assumed if 3 factors were present: (1) complete resection at first surgery, (2) good performance status, and (3) absence of ascites. The DESKTOP II trial was planned to verify this hypothesis prospectively in a multicenter setting.
Original languageEnglish
Pages (from-to)289-295
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume21
DOIs
Publication statusPublished - 2011

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Health Status Indicators
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms
  • Prospective Studies

Fingerprint

Dive into the research topics of 'Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO'. Together they form a unique fingerprint.

Cite this